about
The Bcl-2 apoptotic switch in cancer development and therapyImmortalization of mouse myogenic cells can occur without loss of p16INK4a, p19ARF, or p53 and is accelerated by inactivation of BaxLow-dose radiation-induced enhancement of thymic lymphomagenesis in Lck-Bax mice is dependent on LET and genderDeletion of Bid impedes cell proliferation and hepatic carcinogenesisBax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesisAbsence of the proapoptotic Bax protein extends fertility and alleviates age-related health complications in female mice.p27 deficiency cooperates with Bcl-2 but not Bax to promote T-cell lymphoma.The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.Caspase inhibition blocks cell death and enhances mitophagy but fails to promote T-cell lymphomaA dominant interfering Bub1 mutant is insufficient to induce or alter thymic tumorigenesis in vivo, even in a sensitized genetic background.Elevated mitochondrial superoxide disrupts normal T cell development, impairing adaptive immune responses to an influenza challenge.Purification of germline stem cells from adult mammalian ovaries: a step closer towards control of the female biological clock?Bcl2 family proteins in carcinogenesis and the treatment of cancer.Deconstructing p53 transcriptional networks in tumor suppression.Unravelling mechanisms of p53-mediated tumour suppression.Manganese superoxide dismutase gene dosage affects chromosomal instability and tumor onset in a mouse model of T cell lymphoma.Tumor-Suppressor Functions of the TP53 Pathway.Characterization of the anti-apoptotic mechanism of Bcl-BResistance to apoptosis should not be taken as a hallmark of cancer.Static magnetic field enhances the anticancer efficacy of capsaicin on HepG2 cells via capsaicin receptor TRPV1.
P2860
Q24620437-5F9F54D8-0A59-47A9-9BD8-8DBDEAE2FF21Q24791108-67A3832F-D9DF-4760-8548-A6A1EA0DD18DQ28390732-1E61594F-CBD5-4BCA-9187-D44AE1953960Q28507399-7090986B-5A71-4811-BF14-40254F89A410Q28513038-E770ABDE-F4A7-4F07-AFD7-D1230E2EE761Q30479070-7AB243C5-3413-40C9-9806-E6F4AE04BE39Q33326639-16BDCB40-741A-4F2D-AB58-808F8DD2BFD0Q33756262-F635DE83-655B-48B5-9F4E-5F5BFE75DE76Q33911332-DE49CC7C-06B8-4293-9D2D-54415BE3E111Q33925102-688DBFD4-F1F6-4003-A8B1-863BDF2F6B57Q34516742-8F8A5D62-B1DC-4F72-9858-347CAD2AFF3CQ37227411-2BDBFCBD-7C1C-49FB-A740-B4CA9C78DC71Q37373448-91925D4D-F55A-410A-A525-0E3D44641B1EQ37966330-7190F5BA-B144-4C60-9300-0DE959D4FE69Q38205099-7088D1B9-B672-4D19-B779-CA1C03001BE2Q38276483-84B227A7-CD1F-435C-B365-154FDD938512Q38824332-11661A64-780C-40E5-B924-1B34D8B5E2BAQ41942332-4163A394-AE24-4C3A-9FEE-3BAF8A6DABE9Q41978677-3EA8FF2D-E489-461D-BEED-AC76214BE1CBQ48235127-14D62343-2A59-4183-9B19-321F798FA546
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Bax accelerates tumorigenesis in p53-deficient mice.
@ast
Bax accelerates tumorigenesis in p53-deficient mice.
@en
type
label
Bax accelerates tumorigenesis in p53-deficient mice.
@ast
Bax accelerates tumorigenesis in p53-deficient mice.
@en
prefLabel
Bax accelerates tumorigenesis in p53-deficient mice.
@ast
Bax accelerates tumorigenesis in p53-deficient mice.
@en
P2093
P1433
P1476
Bax accelerates tumorigenesis in p53-deficient mice.
@en
P2093
P304
P407
P577
2001-01-01T00:00:00Z